Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other Accumulated Expenses (2022 - 2023)

Dianthus Therapeutics (DNTH) has 2 years of Other Accumulated Expenses data on record, last reported at $279000.0 in Q2 2023.

  • For Q2 2023, Other Accumulated Expenses changed N/A year-over-year to $279000.0; the TTM value through Jun 2023 reached $279000.0, changed N/A, while the annual FY2022 figure was $364000.0, N/A changed from the prior year.
  • Other Accumulated Expenses reached $279000.0 in Q2 2023 per DNTH's latest filing, up from $224000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $364000.0 in Q4 2022 and bottomed at $224000.0 in Q1 2023.